PBM
Psyence Biomedical Ltd. Common Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
PBM Stock Analysis: Buy, Sell, or Hold?
$3.15
+0.06 (+1.94%)
▲
5d:
+6.42%
30d:
-27.08%
90d:
-12.74%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (94%)
Quality Score
61/100
Position
SLIGHTLY LOW
30-Day Fair Range
$3.14 – $4.61
Position: SLIGHTLY LOW
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.85 / $3.64
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: PBM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When PBM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: PBM is currently trading at $3.15, which is considered slightly low relative to its 30-day fair value range of $3.14 to $4.61.
Technical Outlook: Technically, PBM is in a uptrend. Immediate support is located at $2.85, while resistance sits at $3.64.
Market Sentiment: PBM scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PBM is in a uptrend. Immediate support is located at $2.85, while resistance sits at $3.64.
Market Sentiment: PBM scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.14 -
$4.61
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.1%
Trading Range & Key Levels
30-Day Trading Range
$3.14 -
$4.61
Current vs Trading Range
SLIGHTLY LOW
Support Level
$2.85
Resistance Level
$3.64
Current Trend
Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- CAUTION: Bottoming setup, but lagging the sector by 14% over 20 days — wait for relative strength
Fundamental Context
Share PBM Analysis
Share this live PBM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PBM)
Bullish
3 Retail Mentions
Reddit / WSB Comments
2
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows 100.0% bullish sentiment towards $PBM with the username 'Mooon10' expressing a positive outlook.
Key Retail Themes:
Positive investor sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 10:39 AM ET
Data refreshes hourly during market hours. Next update: 11:39 AM
Data refreshes hourly during market hours. Next update: 11:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PBM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 69 BUY |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 36 SELL |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 41 HOLD |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 48 HOLD |
|
PVLA
Palvella Therapeutics, I… |
STRONG BUY
16 analysts |
$233 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PBM Research Pages
